Reports Archive   Year   
Date Title Pages Source Download
Oct-24 Steady Q2; Revlimid to normalise   9 HDFC Securities
Oct-24 Q2FY25 preview: Seasonality to boost volumes   6 ICICI Securities
Oct-24 Domestic Formulations Strengthen Amid U.S. Generics...   3 Sharekhan
Oct-24 Healthy quarter in the offing   9 Emkay Research
Oct-24 Strong quarter aided by US sales & higher margins   14 Prabhudas Lilladher
Aug-24 Strong performance skirts seasonally weak quarter   10 ICICI Securities
Aug-24 Margin uptick spurs earnings upgrade   10 Nuvama
Jul-24 Q1FY25 preview   7 ICICI Securities
Jul-24 Another strong quarter   6 Sharekhan
Jul-24 Profitability to decline moderately   7 Centrum Research
Jun-24 Pharma EXIM trends   16 Phillip Capital
Jun-24 Strong uptick in gross margin   11 Prabhudas Lilladher
Jun-24 Healthy quarter   6 Sharekhan
May-24 Healthcare Update   106 HDFC Securities
Apr-24 Brimming with opportunities ahead   106 Anand Rathi
Apr-24 Q4FY24 Preview   7 Phillip Capital
Mar-24 Domestic formulations sector secular growth stories   92 HDFC Securities
Mar-24 Erosion remains benign   6 Nuvama
Jan-24 Strong EBITDA growth aided by US markets   14 Prabhudas Lilladher